Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.35 (8.14%)
Bid:
4.65
Ask:
4.80
Spread: 0.15 (3.226%)
Market Cap: £40.44m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Directorate Changes

31 Aug 2023 08:32

RNS Number : 9408K
Revolution Beauty Group PLC
31 August 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For immediate release

31 August 2023

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

Directorate Changes

 

Lauren Brindley to be appointed Group Chief Executive Officer

 

Colin Henry and Chris Fry appointed Independent Non-Executive Directors

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, is pleased to announce the appointment of Lauren Brindley as Group Chief Executive Officer ("CEO") effective on 18 September 2023, and the immediate appointment of Colin Henry and Chris Fry as Independent Non-Executive Directors of the Group.

Appointment of Lauren Brindley as CEO

Lauren Brindley will join the Board as CEO on 18 September 2023, replacing Bob Holt, who as previously announced, will stand down as CEO and leave the business today. Alistair McGeorge will move to the role of Non-Executive Chairman on Lauren's appointment.

Lauren brings a wealth of experience in senior management roles in mass consumer businesses specialising in the Beauty & Personal Care categories. She will be accountable for leading the Group globally, delivering strategic growth, and creating long-term shareholder value.

Lauren was most recently the Group Vice President for Beauty & Personal Care at Walgreens where she was accountable for the American retailer's beauty and personal care strategy and financial delivery across all 9,000+ stores and digital channels. During her tenure at Walgreens, she built a multi-year, multi-stage strategy to elevate and differentiate the business's approach to omnichannel beauty retailing, leading to a positive upswing in its performance in the segment.

Prior to Walgreens, Lauren was at Boots UK and Boots Retail International, where she served in various roles including Head of Prestige Beauty & Fragrance and Head of the No.7 Beauty Brand & Mass Beauty categories, where she led the brand's repositioning strategy. Lauren also served as Country Manager for the business's Southeast Asian operations. Lauren began her career at Tesco UK serving in multiple roles within Marketing and Merchandising.

 

Alistair McGeorge, Executive Chairman, said:

"We are pleased that Lauren will be joining Revolution Beauty at such a critical and exciting time for the Group. Lauren's extensive knowledge of the beauty and retail industries, and proven track record of driving meaningful results, will be critical as we build Revolution Beauty into a global beauty leader.

"I would also like to thank Bob Holt for his contribution during his time as CEO. His work in introducing new protocols across the business and overseeing the lifting of the suspension in trading of the Group's shares means that we are in a good position to pursue the next stage of growth."

 

Lauren Brindley, incoming Chief Executive Officer, commented:

"I'm thrilled to be joining Revolution Beauty at such a pivotal moment for the Group. Revolution Beauty is recognised as one of the fastest product innovators in the sector and the brand has already proven it has global potential. I am excited to join the Revolution Beauty team and bring this amazing brand and our innovative products to consumers across the globe."

 

Appointment of Colin Henry and Chris Fry as Independent Non-Executive Directors

The Company is also pleased to announce the appointment of Colin Henry and Chris Fry as Independent Non-Executive Directors of the Group.

They will replace Jeremy Schwartz, Rachel Maguire and Matthew Eatough, who informed the Board that as they are not standing for re-election at the AGM, they are resigning their positions as Independent Non-Executive Directors and stepping down from the Board. Colin and Chris were identified following a search led by the Nomination Committee, and these changes take effect from today.

Colin brings over 30 years' experience in multinational retail businesses having previously held senior roles at Marks & Spencer PLC, Polo Ralph Lauren, Nike / Umbro, Jaeger, and New Look. Colin is an experienced Senior Advisor and Executive Director with a global perspective and international experience. He comes with a proven track record for delivering results in both luxury and mass markets, with a passion for brand, design, and omnichannel retail.

Chris is an accomplished executive with more than 30 years of finance and commercial experience. Chris began his career at PwC where he qualified as a chartered accountant, before later serving as a Senior Partner and Head of KPMG's Liverpool office. Currently serving as Chief Financial Officer of FinTech company BankiFi, Chris has advised numerous listed and private companies in board positions across a variety of commercial sectors.

 

Alistair McGeorge, Executive Chairman, said:

"Colin and Chris both bring with them highly relevant experience that will benefit the Group and its future. I am very pleased to welcome them to the Board.

"I would also like to take this opportunity to thank Jeremy, Matthew and Rachel for their contribution to the business."

 

Lauren, Colin, and Chris currently hold no shares in the Company.

The following information regarding the appointment of Lauren Elizabeth Brindley, aged 44, is disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:

Current directorships and partnerships:

Indu Cosmetics Ltd

The following information regarding the appointment of Colin Glen Henry, aged 58, is disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:

Current directorships and partnerships:

East Imperial Plc

Silverwells Consultants Limited

In addition, Colin has held the following directorships in the past five years:

St George's Drive SW1 Ltd

The following information regarding the appointment of Christopher Ramon Fry, aged 60, is disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:

Current directorships and partnerships:

Less Admin US Inc

Less Admin Limited

BankiFi Technology Ltd

CCF Business Services Limited

In addition, Chris has held the following directorships in the past five years:

Liverpool City Region Growth Company (Holdco) Limited

Liverpool City Region Growth Company Limited

The Contact Company Ltd

The Contact Specialists Ltd

Tower Wharf Ltd

Buxton Arts Festival Limited

 

For further information please contact:

Investor Relations

Elizabeth Lake

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Zeus (NOMAD): Nick Cowles /Jamie Peel /Jordan Warburton

Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt

 

Tel: +44 (0) 161 831 1512

Tel: +44 (0) 203 100 2222

Media enquiries

Headland Consultancy

Matt Denham / Will Smith / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

 

 

The person responsible for arranging the release of this announcement on behalf of the Company is Elizabeth Lake, the Chief Financial Officer of the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAXPFDAFDEEA
Date   Source Headline
7th Mar 20232:00 pmRNSRevised deferred consideration for Medichem
21st Feb 20237:00 amRNSUpdate on FY22 Audit
13th Jan 20237:00 amRNSOutcome of Independent Investigation
16th Dec 20222:35 pmRNSDirectorate Change
28th Nov 20222:24 pmRNSHolding(s) in Company
28th Nov 20227:00 amRNSAppointment of CEO
25th Nov 20224:27 pmRNSTR-1: Standard notification of major holdings
9th Nov 20229:05 amRNSDirectorate Change
27th Oct 20225:30 pmRNSSuspended Companies Notice – Deletions
14th Oct 20227:00 amRNSUpdate on Independent Investigation
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
23rd Sep 20227:00 amRNSFurther update on the Group’s audit
7th Sep 20227:00 amRNSTR-1: Standard notification of major holdings
1st Sep 20227:30 amRNSSuspension - Revolution Beauty Group plc
30th Aug 20227:00 amRNSUpdate on Publication of Final Results
19th Aug 20222:30 pmRNSFurther update on the Group’s audit
17th Aug 20226:20 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:15 pmRNSTR-1: Standard notification of major holdings
17th Aug 20226:00 pmRNSTR-1: Standard notification of major holdings
17th Aug 20227:05 amRNSStrategic Investment in Revolution Beauty Group
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
17th Aug 20227:00 amRNSTR-1: Standard notification of major holdings
12th Aug 20221:55 pmRNSTR-1: Standard notification of major holdings
11th Aug 20224:41 pmRNSSecond Price Monitoring Extn
11th Aug 20224:35 pmRNSPrice Monitoring Extension
11th Aug 202211:05 amRNSUpdate on the Group’s audit
11th Aug 202210:10 amRNSTR-1: Standard notification of major holdings
5th Aug 20221:20 pmRNSTR-1: Standard notification of major holdings
3rd Aug 20223:45 pmRNSTR-1 Standard notification of major holdings
2nd Aug 20227:00 amRNSTrading update and change to results date
30th Jun 20227:00 amRNSCorporate Broker Appointment and Notice of Results
17th Jun 20227:00 amRNSNOTIFICATION OF MAJOR HOLDINGS
12th May 20227:00 amRNSAppointment of Chief Financial Officer
11th May 202211:40 amRNSHolding(s) in Company
6th May 20227:00 amRNSFull Year Trading Update
25th Feb 20227:00 amRNSAcquisition
23rd Feb 20225:50 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSTrading Update
24th Nov 20217:00 amRNSInterim Results
27th Oct 20217:00 amRNSAcquisition of Medichem Manufacturing
27th Sep 20217:00 amRNSH1 Trading Update and Notice of Results
20th Aug 202111:47 amRNSIssue of Shares under Share Incentive Plan & TVR
23rd Jul 202112:08 pmRNSImplementation of Long Term Incentive Plan
22nd Jul 20215:35 pmRNSNotification of Major Holdings
21st Jul 20217:00 amRNSNotification of Major Holdings
20th Jul 20215:59 pmRNSDirector Dealing
19th Jul 20217:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.